BioXcel Therapeutics Inc
F:BX2
BioXcel Therapeutics Inc
F:BX2
Price:
2.56
EUR
Market Closed
Market Cap:
€96.1m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
B
|
BioXcel Therapeutics Inc
F:BX2
|
US |
|
Kansai Paint Co Ltd
TSE:4613
|
JP |
|
Korea United Pharm Inc
KRX:033270
|
KR |
|
A
|
Almirall SA
XBER:E2Z
|
ES |
|
International Personal Finance PLC
LSE:IPF
|
UK |
|
C
|
CIMIC Group Ltd
XBER:LTH
|
AU |
|
C
|
CITIC Pacific Special Steel Group Co Ltd
SZSE:000708
|
CN |
|
S
|
Solvay SA
XBER:SOL
|
BE |
|
B
|
Basic Net SpA
F:BCJ
|
IT |
|
A
|
Anima Holding SpA
F:124
|
IT |
|
T
|
Tempus AI Inc
NASDAQ:TEM
|
US |
|
DSM-Firmenich AG
F:ZX61
|
CH |
|
Wall Street Finance Ltd
BSE:511147
|
IN |
|
OceanaGold Corp
F:RQQ0
|
CA |
|
M
|
ManpowerGroup Inc
XMUN:MPW
|
US |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BX2's stock price target?
Not Available
BX2 does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for BioXcel Therapeutics Inc?
Projected CAGR
147%
147%
The compound annual growth rate for Revenue over the next 8 years is 147%.
What is the Gross Profit forecast for BioXcel Therapeutics Inc?
Projected CAGR
153%
153%
The compound annual growth rate for Gross Profit over the next 8 years is 153%.
